PAISLEY CHRISTOPHER B sold $16K of AMBA

PAISLEY CHRISTOPHER B sold 250 shares of AMBARELLA INC (AMBA) at $62.01 on 2026-06-26 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · PAISLEY CHRISTOPHER B
Published Jun 30, 2026, 9:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 30, 2026, 9:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AMBA
Neutral
medium confidence
Mentioned
$AMBA
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMBANeutralLow
01

Why it matters

Because the sale is pre-arranged and relatively small in dollar terms, it typically carries less informational weight than unscheduled sales or buys.

02

Market read

Traders may log the transaction for insider-flow monitoring, but it is unlikely to drive a standalone repricing.

03

What to watch

The article provides only one small sale; without context on total insider holdings, other transactions, or subsequent buys, signal quality is limited.

Relevance 2/10Novelty 4/10Timing: Form 4 filed after-hours/late day (2026-06-30), for next-session positioning

Background

The disclosure is an SEC Form 4 insider transaction by a director, specifying an open-market sale executed under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$AMBANeutralMedium confidence
Context

AmbaRELLA director Paisley Christopher B sold 250 shares at $62.01 under a pre-arranged 10b5-1 plan, per Form 4 filed today.

Expected impact

Low near-term impact; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a Form 4 open-market sale with a stated 10b5-1 plan, and the disclosed value (~$15.5k) is small relative to typical market moves.

Market effects

No sector read-across; this is company-specific insider transaction reporting.

None indicated.

None indicated.

Counterpoint

Even 10b5-1 sales can coincide with internal views on near-term risk, so traders may still watch for follow-on insider activity.

Key entities

  • AMBARELLA INC

    Company whose director insider sale is reported on SEC Form 4.

  • PAISLEY CHRISTOPHER B

    Director who sold 250 shares at $62.01 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMBAMed

Ambarella (AMBA) Shares Rise 2.4% Amid Nvidia Acquisition Specul

Ambarella (AMBA) shares rose 2.4% on reports Nvidia (NVDA) may join acquisition talks, alongside NXP (NXPI) and Qualcomm (QCOM). The company's P/S ratio is 6.7x, below historical and industry medians, reflecting market skepticism. Insider activity shows $17.1M in sales over the past year. Ambarella specializes in low-power semiconductor solutions for video and AI applications.

$AMBAHighAI 8/10

Ambarella speculated to have a rival suitor - Betaville

Ambarella (AMBA) may have a second potential buyer, following reports of NXP Semiconductors (NXPI) exploring an acquisition. Traders suggest a bid of 75% cash and 25% shares, valued between $95 and $105 per share, citing a Betaville alert. The identity of the new suitor is unknown.

$AMBAHighAI 9/10

ZEDEDA Deal Targets $30B Edge AI Market

Ambarella and ZEDEDA announced a partnership on September 15, 2026, integrating ZEDEDA's EVE-OS with Ambarella's N1 edge AI chips. The deal targets the $30B edge AI market, with developer kits expected in Q4 2026. Ambarella reported Q2 2026 revenue of $108.1M, up 13.2% YoY, while ZEDEDA has raised over $129M in funding.